Health Care

Michigan's attorney general said Wednesday she sought court approval to investigate Eli Lilly and Co., accusing the drugmaker of charging excessive prices for insulin medications used to treat diabetes.

COVID-19 deaths in the U.S. have reached the highest level since early last year, eclipsing daily averages from the recent delta-fueled surge, after the newer omicron variant spread wildly through the country and caused record-shattering case counts.

COVID-19 vaccine-makers Pfizer and BioNTech announced Tuesday that the companies would test an omicron-specific vaccine candidate in healthy adults ages 18 to 55.

The Department of Homeland Security (DHS) said that beginning Saturday it will require non-U.S. individuals hoping to enter the U.S. via land ports of entry and ferry terminals at the U.S.-Mexico and U.S.-Canada borders to be fully vaccinated against COVID-19.

A new online pharmacy has been launched with a billionaire's backing.

A new, wearable device could give you an early warning that you've been exposed to COVID-19.

The United Nations-backed initiative to equally distribute COVID-19 vaccines is low on funds.

Pfizer Inc. said Tuesday that laboratory testing showed its COVID-19 pill Paxlovid appears to be effective against the omicron variant of the coronavirus.

The CDC's maritime unit will work closely with participating cruise ships, monitoring COVID-19 preventive measures and onboard cases through daily enhanced data collection and inspections.

Canada’s health regulator has approved a pill by Pfizer that treats the effects of COVID-19.

The antiviral covid-19 pills developed by U.S. firms are the next step in the pandemic battle.

WalletHub published a report that found how much it costs to be a smoker per year and over the course of a lifetime in all 50 U.S. states and Washington, D.C.

A new law requires private health plans to cover surprise bills at in-network rates based on the median cost of care for similar services.

Dr. Jerome Adams says Biden has left it up to businesses to "take control" of the COVID-19 pandemic.

The U.S. Centers for Disease Control and Prevention warned Americans this week against traveling to Canada, due to what it deemed a "Very High" level of COVID-19 infections in the country.

Medicare said Tuesday it will limit coverage of a $28,000-a-year Alzheimer’s drug whose benefits have been widely questioned, a major development in the nation’s tug-of-war over the fair value of new medicines that offer tantalizing possibilities but come with prohibitive prices.

There is a growing debate on whether people testing for omicron should swab their throats.

More workers are set to be fired from several companies this month over vaccine mandates.

Department of Health and Human Services Secretary Xavier Becerra has asked Medicare to reassess its 2022 premium increase after Biogen slashed the cost of its expensive new Alzheimer's drug, which was part of the reason for the boost.

As omicron continues to surge in New York, the state's tourism is reportedly taking a hit.